Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...

Earlier in the week, Novartis said it entered into an agreement with Avidity Biosciences, Inc. (NASDAQ:RNA) to acquire the ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

Fintel reports that on October 28, 2025, Chardan Capital downgraded their outlook for Avidity Biosciences (NasdaqGM:RNA) from ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

Cells contain a blueprint in the form of DNA that dictates what they can make.This blueprint is converted into a message, or mRNA, which is then ...

Novartis will acquire Avidity Biosciences for $12 billion at $72 per share, gaining its RNA-targeting platform and neuroscience pipeline as Avidity spins off its precision cardiology programs into a ...

A new study published in Nature Biotechnology shows that stem cell differentiation is linked to cellular structures called ...

Avidity Biosciences (RNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The University at Albany and Virginia Commonwealth University were awarded a $6.5 million NIH grant to establish a federal ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.